EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis

Ricardo E T Navarrete, Joao Fernandes, Isabel Fonseca, José Luis Silvano, La Salete Martins, Joao Roberto Sa

Diabetes Epidemiology and Management · 2026 · 21 · 100302

DOI: 10.1016/j.deman.2026.100302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Epidemiology and Management, 2026. Verfasst von Ricardo E T Navarrete und 5 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Navarrete, R. E. T., Fernandes, J., Fonseca, I., Silvano, J. L., Martins, L. S., & Sa, J. R. (2026). Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis. Diabetes Epidemiology and Management, 21, 100302. https://doi.org/10.1016/j.deman.2026.100302

Vancouver

Navarrete RET, Fernandes J, Fonseca I, Silvano JL, Martins LS, Sa JR. Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis. Diabetes Epidemiology and Management. 2026;21:100302. doi:10.1016/j.deman.2026.100302

BibTeX
@article{Navarrete2026,
  author = {Navarrete, Ricardo E T and Fernandes, Joao and Fonseca, Isabel and Silvano, José Luis and Martins, La Salete and Sa, Joao Roberto},
  title = {Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis},
  journal = {Diabetes Epidemiology and Management},
  year = {2026},
  volume = {21},
  pages = {100302},
  doi = {10.1016/j.deman.2026.100302}
}
Kostenlos starten →